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 2 
Abstract 22 
The World Health Organization End tuberculosis (TB) strategy has called for development of- 23 
and increased access to- effective tools for diagnosis and treatment of TB disease. 24 
Mycobacterium tuberculosis (Mtb), the causative agent of TB is categorized as highly infectious 25 
agent. Consequently, diagnostic tests that involve comprehensive manipulation of specimens 26 
from presumed tuberculosis cases must be performed in a category three laboratory. We have 27 
evaluated the use of heat-inactivation to render TB samples safe to work with whilst preserving 28 
RNA for downstream molecular tests. Using Mycobacterium bovis Bacillus Calmette Guérin 29 
(BCG) cultures and TB positive sputa we show that boiling for 20 min at 80-, 85-, and 95- 
o
C 30 
inactivates all Mtb bacilli. The efficiency of inactivation was verified by culturing heat-treated 31 
and untreated (live) fractions of BCG and TB sputum for 42 days. No growth was observed in 32 
the cultures of heat-treated samples. In contrast the optical density of untreated BCG in 33 
Middlebrook 7H9 broth rose from 0.04 to 0.85 and the untreated sputa flagged positive at 3 days 34 
of incubation in Mycobacterium Growth Indicator Tube. Quantification of reference genes, 16S 35 
rRNA, tmRNA, pre-16S rRNA and rpoB by Reverse transcriptase quantitative polymerase chain 36 
reaction (RT-qPCR) showed minimal loss in estimated bacterial load. The loss was RNA-species 37 
dependent, <1log10, 1.1log10, 1.3log10 and 2.4log10 estimated CFU/ml for 16S rRNA, tmRNA, 38 
pre-16S and rpoB respectively. The RNA loss was independent of inactivation temperature. 39 
These findings show that heat-inactivation could obviate the need for category three laboratory 40 
to perform RNA-based testing of TB samples. 41 
 42 
 43 
 44 
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 3 
Introduction 45 
Tuberculosis (TB) caused by Mycobacterium tuberculosis (Mtb) is a leading infectious disease 46 
killer claiming over a million lives every year world-wide. Close to 10 million new cases were 47 
reported in per year, 2016 and 2017(1, 2). Development of effective diagnostic and treatment 48 
tools is the main aim of pillar three of the End TB strategy(3). Mtb is classified under category 49 
three infectious organisms, requiring most research and diagnostic procedures to be conducted in 50 
high containment laboratories especially when the organism is to be cultured. Construction and 51 
maintenance of category three laboratories is costly, and consequently most high-burden low- 52 
and middle- income countries consolidate such services at regional or national level. 53 
Consequently, culture laboratories are hundreds of kilometers away from most people that need 54 
the service. This severely limits access to these facilities, slowing or preventing effective 55 
diagnosis and treatment of tuberculosis.  In addition, health care facilities are forced to rely on 56 
less sensitive or specific methods such as microscopic examination of sputum smears, which are 57 
limited by low sensitivity and specificity failing to distinguish viable from dead bacilli.  58 
 59 
Molecular tests like Xpert MTB/RIF have approval from WHO for implementation at district 60 
hospital level to provide rapid diagnosis of TB(4, 5). The main challenge of Xpert MTB/RIF is 61 
the detection of DNA, a stable molecule that hangs around long after cell death, and cannot 62 
therefore be used for monitoring treatment response(5, 6). RNA-based assays have been 63 
developed to overcome this challenge(7–13). There are different species of RNA, ribosomal, 64 
transfer and messenger, which vary in stability and copies per cell. Messenger RNA is the least 65 
stable, degrading rapidly after cell death(14). Ribosomal and transfer RNAs are structural RNAs, 66 
relatively more stable than mRNA(14). By this definition mRNA is the most ideal marker for 67 
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 4 
cell viability, however, its fast degradation and existence as a low copy molecule compromises 68 
its utility as a marker in a diagnostic test.   69 
 70 
We have published a method, molecular bacterial load assay (MBLA) that used rRNA to identify 71 
M. tuberculosis and quantify the total viable count in a single molecular reaction(15). This 72 
showed that the amount of 16S rRNA proportionally increased with bacterial growth measured 73 
by colony forming units (CFU) counts(11, 13, 16). In response to treatment the fall in CFU 74 
counts was matched by corresponding decline of 16S rRNA measured by a semi-quantitative 75 
reverse transcriptase PCR, suggesting that the latter is a good marker of cell viability(13, 16).  76 
The current MBLA protocol requires the first steps of TB sample processing be performed in a 77 
high containment laboratory until all Mtb cells have been lysed.  It also includes sample 78 
preservation with Guanidine thiocyanate (GTC), a hazardous class four chemical that requires 79 
special precautions to work with and samples should be maintained at -80
o
C if they are to be 80 
tested later.  The need for simple and user friendly but safe TB sample handling cannot be more 81 
emphasized. 82 
 83 
The MBLA is currently a research use only (RUO) test.  It is being used by a range of research 84 
groups in Eastern and Southern Africa, UK, Netherlands, Germany, Thailand and Vietnam who 85 
are sing the test to monitor response to anti-TB therapy in clinical trials of standard and test 86 
regimens and/or diagnostic evaluation studies. Although developed and optimized to detect and 87 
quantify TB in sputum samples, groups in Public Health England and Vietnam have successfully 88 
applied MBLA to quantify bacterial load in Guinea pig lung tissues and cerebral spinal fluid 89 
from TB meningitis patients respectively (manuscripts in preparation). Results from multisite 90 
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evaluation in Africa (manuscript in preparation) and previous publications(17, 18) show that the 91 
sensitivity of MBLA is consistent with MGIT liquid culture and higher than that of solid culture. 92 
An important difference between MBLA and liquid culture is that MBLA is not affected by non-93 
TB contaminants in the specimen and gives quantitative bacterial burden results in real-time.  94 
This means that the results can inform clinical decision for patient management. Based on these 95 
findings, the MBLA was recently recognized by World Health Organization as biomarker for TB 96 
treatment monitoring with potential to replace smear and culture(2). 97 
 98 
Heat treatment is an established technique that has been used to decontaminate medical devices, 99 
ensure aseptic inoculation and in therapeutic preparations(19, 20). However, for Mtb, reports 100 
have shown that short slide flaming or drying on hot block is insufficient to completely 101 
inactivate all bacilli(21, 22). Heating Mtb cultures at 80C for 20min was shown to be effective 102 
at inactivating Mtb without compromising the integrity of DNA for downstream 103 
manipulation(23).  Currently, a number of DNA isolation techniques use heating at 95
o
C as part 104 
of their procedure, suggesting such heat is not detrimental to nucleic acid integrity. However, 105 
studies have shown DNA as stable molecule that survives long after cell death, which makes it a 106 
poor marker of cell viability and monitoring of bacteriologic response to therapy(6).  107 
 108 
The present study aimed to evaluate whether samples containing Mycobacterium tuberculosis 109 
complex organisms can be heat-inactivated without compromising the detection of different 110 
RNA species that could be used to estimate bacterial load. Our data report a simple method to 111 
render TB samples non-infectious potentially obviating the need for a high containment 112 
laboratory while performing molecular assays like MBLA. 113 
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 114 
Materials and Methods 115 
Study site and samples  116 
The study was conducted at the University of St Andrews United Kingdom and the Mozambique 117 
National Tuberculosis Reference Laboratory (NTRL) in Maputo.  118 
 119 
Two types of samples were used, the clinical sputum from TB patients and in vitro cultures of 120 
Bacillus Calmette Guérin (BCG). Smear positive TB sputum samples were obtained from the 121 
routine and emergency TB laboratories at Mavalane Health Centre and Maputo Central Hospital 122 
in Maputo city, Mozambique. At the NTRL, presence of Mtb in the specimens was further 123 
confirmed by Xpert MTB/RIF. None of specimens was rifampicin resistant. The sputa (from 124 
different patients) were then pooled, homogenized and 1 mL aliquots prepared for the different 125 
downstream test conditions, heat inactivation and decontamination with NALC/NaOH for 126 
culture. Eight 1 mL aliquots of pooled sputum prepared for inactivation at each temperature. 127 
Two repeats were performed each involving a batch of pooled sputum from the patients.  128 
 129 
BCG cultures were cultivated and processed at the University of St Andrews to explore the effect 130 
of heat-inactivation on RNA prior to processing clinical sputum. 131 
 132 
Culture 133 
BCG was propagated in Middlebrook 7H9 broth at 37C for 19 days prior to use. The 7H9 134 
medium was made of 7H9 broth with 2% v/v glycerol, 1% v/v Tween 80 and 10% v/v ADC 135 
supplement. The cultures were harvested into the 15mL centrifuge tubes (Thermofisher 136 
 o
n
 February 13, 2019 by guest
http://jcm.asm.org/
D
ow
nloaded from
 
 7 
scientific, UK) and tightly closed.  Eight 2mL aliquots were processed per culture batch for each 137 
condition. Three independent batches of culture were processed. 138 
 139 
Sample inactivation 140 
Both clinical sputa and BCG cultures were inactivated for 20min in a non-shaking water bath at 141 
80C, 85C and 95C to kill all mycobacteria and assess the impact on the amount of bacterial 142 
load (CFU/ml) estimated from the total RNA harvested from the cells. The inactivation 143 
temperatures were selected based on previous study(23) and now commonly used in laboratory 144 
molecular preparations. Sample boiling was done in tightly closed 15ml centrifuge tubes, which 145 
were left to stand for 10 min to allow any aerosols to settle prior to opening. Controls were 146 
clinical sputa or culture aliquots not exposed to heat (untreated). Inactivation was confirmed by 147 
cultivating the heat-killed fractions and controls in Middlebrook 7H9 broth. Controls and 148 
inactivated BCG cultures were inoculated at 1:9mL into the growth medium whilst clinical sputa 149 
were inoculated at 0.5mL into Mycobacterium Growth Indicator Tube (MGIT) growth medium 150 
(BD Ltd). Optical density at 600nm of liquid culture was measured before and weekly during 151 
incubation at 37C for 42 days to confirm no growth in heat-inactivated fractions. Growth or no 152 
growth of clinical sputa was automatically determined by MGIT over 42 days of incubation.  153 
 154 
RNA extraction and quantitative PCR 155 
RNA extraction and Reverse transcriptase quantitative polymerase chain reaction (RT-qPCR) 156 
were performed according Honeyborne et al proposed procedures(18). Briefly, BCG cultures and 157 
Xpert MTB/RIF positive sputa were spiked with standard internal control as described in 158 
Honeyborne et al and Gillespie et al(15, 18)  and centrifuged at 3000g for 30min. The sediment 159 
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 8 
was suspended in lysis buffer, RNA pro blue solution (MP Biomedicals, UK), and bead 160 
homogenized for 40 seconds at 6000rpm using the Precellys 24 (pEQlab, UK) homogenizer. 161 
RNA was isolated using FASTprep RNA kit (MP Biomedicals, UK) according to the 162 
manufacturer’s instructions. Genomic DNA was removed from the extracts by a 1h DNase 163 
treatment at 37°C using the Ambion Turbo DNase kit (Life Technologies, UK). 164 
 165 
The RT-qPCR was performed on a RotorGene 5plex platform (Qiagen, UK) using primers and 166 
dual labelled hydrolysis probes (Taqman) targeting Mtb complex 16S rRNA, transfer messenger 167 
RNA (tmRNA), precursor 16S (pre-16S) rRNA and RNA polymerase B (rpoB) genes and the 168 
internal control. All primers and probes were procured from MWG Eurofins, Germany. The 169 
optimal PCR conditions and translation of quantification cycles (Cq) into bacterial load 170 
(estimated colony forming units, eCFU/mL) were as described in Honeyborne et al and Gillespie 171 
et al(15, 18). Briefly, the MBLA RT-qPCR limit of detection is 10 CFU/ml equivalent to 30Cq 172 
cut off. RNase free molecular grade and no Reverse transcriptase sample were included in each 173 
assay run as negative and DNA contamination controls respectively. 174 
 175 
Note: The Internal control, primers and probes have now been incorporated into the MBLA kit 176 
under the trademark Vitalbacteria. Consequently, the internal control, the primer and probe 177 
sequences cannot be published. 178 
 179 
Statistical analysis 180 
All analyses were performed using GraphPad Prism v.6. One-way ANOVA test was used to 181 
calculate difference in the mean bacterial load (log10eCFU/ml) of the control (from live BCG or 182 
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 9 
Mtb) and heat-inactivated fractions. Sidak’s multiple comparisons test was used to test whether 183 
the mean bacterial load at 80°C, 85°C and 95°C was different. The Sidak’s test was selected 184 
because of its power to compare a set of means and provide a p value of the difference; a p value 185 
less than 0.05 was considered significant. 186 
 187 
Ethics 188 
The study was nested in the Pan-Africa Biomarkers expansion programme (PANBIOME) for 189 
performance evaluation of the molecular bacterial load assay (MBLA).  The study was approved 190 
by the University of St Andrews teaching and research ethics committee and by the Institutional 191 
Review Board of Instituto Nacional de Saúde and the National Bioethical Committee (CNBS) in 192 
Mozambique. 193 
 194 
Results 195 
Heat inactivates all mycobacteria: The OD of heat inactivated BCG samples remained 196 
unchanged over the 42 days of incubation whereas the optical density of untreated samples 197 
increased from 0.04OD to 0.85OD (Figure 1).   Similarly, untreated clinical sputa flagged positive 198 
in MGIT at day 3 of incubation whilst the heat-inactivated sputa remained negative throughout 199 
the culture period. Presence of Mycobacterium tuberculosis in the positive MGIT culture was 200 
confirmed with Ziehl-Neelsen microscopy and antigen MPT64(24). None of the heat killed sputa 201 
grew positive for 42 days of incubation. 202 
  203 
Effect of heat-based sample inactivation on bacterial load measured by 16S rRNA as 204 
marker: Compared to control (live) BCG 5.260.21log10eCFU/ml the mean bacterial load 205 
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 10 
significantly reduced to 5.110.29, 5.130.23 and 4.910.24 log10eCFU/ml, when cells were 206 
killed at 80
o
C, 85
o
C and 95
o
C respectively, ANOVA p<0.0001 between controls and heat-207 
inactivated samples. Pairwise comparison revealed no significant difference between control and 208 
80
o
C and 85
o
C, implying that the ANOVA p value was driven by the low bacterial load at 95
o
C 209 
compared to the control. The reduction in measured bacterial load at the same temperatures was 210 
0.14, 0.13 and 0.35 log10eCFU/ml resulting in an average reduction of 0.210.12 log10eCFU/ml 211 
for all temperatures combined (Figure 2A).  A similar trend was observed when the conditions 212 
were applied to clinical sputa from TB patients. The control Mtb bacterial load was 7.10 213 
reducing to 6.430.76, 6.230.12 and 6.200.45 log10eCFU/ml at 80
o
C, 85
o
C and 95
o
C, 214 
ANOVA p<0.0001 respectively. This resulted in measured bacterial load reduction of 0.67, 0.88 215 
and 0.89 log10eCFU/ml and a combined average reduction of 0.820.12 log10eCFU/ml (Figure 216 
2B). 217 
 218 
Using the Sidak’s multiple comparisons test, we asked whether the mean bacterial load was 219 
different between the three heat-inactivation temperatures. We found the mean bacterial load, 220 
4.91 log10eCFU/ml for BCG cultures inactivated at 95
o
C was significantly lower than 5.26, 5.11 221 
log10eCFU/ml at 80
o
C and 85
o
C, p=0.001 respectively. In contrast, there was no difference in the 222 
bacterial load of Mtb samples at all the three temperatures, p=0.77. 223 
 224 
Effect of heat-based sample inactivation on bacterial load measured by other RNA species: 225 
tmRNA, pre-16S rRNA and rpoB: We explored what effect similar heat killing conditions had 226 
on other RNA species that are potential markers for quantifying tuberculosis bacterial load. The 227 
mean bacterial load of the control was 5.940.12, 5.250.02 and 4.560.09 log10eCFU/ml for 228 
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 11 
tmRNA, pre-16S rRNA and rpoB respectively. The bacterial load at 80
o
C, 85
o
C and 95
o
C were 229 
tmRNA 4.760.54, 5.050.16 and 4.850.59 log10eCFU/ml, pre-16 rRNA 3.850.47, 3.970.14 230 
and 4.030.35 log10eCFU/ml and rpoB 2.290.09, 2.030.22 and 2.150.39 log10eCFU/ml. Like 231 
16S rRNA, the bacterial load of the control and the heat killed samples were significantly 232 
different, ANOVA p<0.0001 for all the three RNA species. (figure 3A, B and C). However, by 233 
Sidak’s multiple comparison test, the bacterial load did not vary significantly between the 234 
different heat killing temperatures within each RNA species. 235 
 236 
The rate of bacterial load loss varies with RNA species: Whilst there was no difference in 237 
intra-RNA species’ bacterial load loss at different heat killing temperatures, it varied between the 238 
RNA species tested. 16S rRNA had the lowest loss in both, pure BCG culture, 0.210.12 and TB 239 
sputum, 0.820.12 log10eCFU/ml.  The highest loss was observed with rpoB, 2.400.13 240 
log10eCFU/ml in TB sputum. Transfer mRNA and pre-16S rRNA were in between with loss of 241 
1.050.15 and 1.300.09 log10eCFU/ml respectively (Figure 4). 242 
 243 
Discussion 244 
We have shown that heat treatment for 20 min at 80
o
C, 85
o
C and 95
o
C inactivates tuberculosis 245 
specimens effectively, making it possible for downstream molecular tests to occur without risk of 246 
infection. These findings concur with Doig et al and contrast with Zwadyk et al’s conclusion that 247 
temperatures less than 100
o
C cannot consistently kill Mtb(23, 25). In line with Zwadyk et al’s 248 
observations some studies have indicated that 80
o
C may not inactivate samples with a high 249 
bacterial load or high-density cultures of Mtb completely (23, 26–28). To remove the effect of 250 
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high-density inoculum in our study, all sputa and pure cultures were heated at 1ml volume per 251 
15ml centrifuge tube providing adequate space to expose every part of the sample to boiling. 252 
 253 
Unlike the two studies which evaluated DNA as a molecular marker, our study has evaluated 254 
preservation of RNA following heat inactivation. Our study adds evidence to studies which 255 
showed that RNA could be preserved following heat-inactivation of bacteria(12, 29). We show 256 
that the amounts of RNA preserved are sufficient for downstream qualitative and potentially for 257 
quantitative molecular tests like MBLA and other Reverse Transcriptase PCR diagnostics of 258 
bacterial pathogens based on the same principle. Modifications of the Mtb MBLA principle 259 
could be used to quantify the viable bacterial load of different pathogens.  Heat inactivation may 260 
obviate the need to use high containment laboratories for RNA-based tests of category 3 bacterial 261 
pathogens. 262 
 263 
By analyzing four RNA markers, 16S rRNA, tmRNA, pre-16S rRNA and rpoB we demonstrate 264 
that the amount of RNA preserved depends on the RNA species and is independent of 265 
temperature. Of the four RNA species, 16S rRNA was most resilient with <1 log bacterial load 266 
loss compared to rpoB, the most vulnerable with >2 logs of bacterial load loss.  267 
 268 
The bacterial load measured in the control (live) samples was consistently higher than the heat 269 
inactivated ones. However, the loss did not increase with higher temperatures. This suggests that 270 
the loss is most likely not due to heat induced RNA degradation as this would in principle 271 
increase with increasing temperature. We hypothesize heating at these temperatures lyses some 272 
of the cells exposing RNA to RNases present in the sample and the extent of degradation is 273 
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dependent of how susceptible the RNA species are to these enzymes.  The RNA species 274 
dependent loss could be explained by the different susceptibilities the species have to RNase and 275 
the amount of contaminant RNase present in the sample. For instance, it is notable that the rate 276 
of RNA loss in BCG cultures was lower than that in TB sputum for 16S rRNA. The lower 277 
degradation, 0.23 log10eCFU/ml of 16S rRNA in BCG pure cultures could be explained by low 278 
concentrations of RNase in pure cultures compared to clinical sputum samples in which both 279 
host- and Mtb- generated RNases are most likely present(30, 31).  280 
 281 
16S rRNA is a structural RNA constituting the smaller unit of prokaryotic ribosome, which 282 
potentially makes it less susceptible to RNase(32, 33). Furthermore, a single Mtb cell contains 283 
hundreds of ribosomes, 700/0.1m3 of cytoplasm(32) implying higher quantities rRNA for 284 
which little quantities of RNase may have less impact(33). Transfer messenger RNA is a 285 
combination of two RNA species, transfer and messenger and has also been shown to have 286 
higher structural stability than mRNA(34). It is not clear what structural stability, pre-16S rRNA 287 
has since it is a precursor (transition) molecule. Drawing on the results of the rate of RNA loss in 288 
this study, the structural stability of pre-16S rRNA could be between mRNA and tRNA. RNA 289 
polymerase B (rpoB) which is messenger RNA is more susceptible. It was shown that Mtb 290 
mRNA has a half-life of 9 min at 37
o
C, however, when temperatures were reduced to 20
o
C, the 291 
half-life was significantly increased to more than 5h(35). The 9min rate of degradation at 37
o
C is 292 
expected since this is the temperature at which most physiological reactions take place. Probably 293 
the reason we have not seen fast degradation at 80
o
C and above temperature is that they are not 294 
optimal temperatures for RNase function.  295 
 296 
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Heat inactivation has been used over centuries for many functions including disinfection of 297 
medical devises and therapeutic preparations, aseptic inoculation and preparation smears for 298 
microscopy in microbiology laboratories, and in pasteurization of milk. This means that the heat 299 
inactivation as a technique already has a place in the clinical laboratory and can easily be 300 
deployed to processing samples for RNA-based tests. The current standard of TB culture uses 301 
decontamination step with NaOH to remove non-mycobacterial flora in sputum but this 302 
unfortunately reduces the viable Mtb load by 1-2 logs(36, 37).  The degree of loss that we show 303 
here with heat inactivation is less than that of NaOH-induced loss of viability, which places the 304 
impact of this procedure in context especially as MBLA obviates the need for NaOH treatment 305 
of sputum. 306 
 307 
This study has shown that heat treatment of sputum samples renders them safe whilst preserving 308 
RNA for downstream laboratory tests. This potentially obviates the need for category 3 309 
laboratories to manipulate TB specimens for molecular tests. Since the amount of RNA 310 
preserved is RNA species-dependent, it is crucial for species specific optimization to be 311 
conducted prior to adoption for routine application. RNA is more susceptible to degradation than 312 
DNA but could survive longer if it was not for the universally present and highly stable 313 
RNases(38). Future studies will explore the impact of heat inactivation on samples with a range 314 
of bacterial loads to understand the number that might change from positive to negative, i.e., 315 
those with fewer bacteria. 316 
 317 
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Figures 458 
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Figure 3 466 
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Figure 4 473 
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Figure legends 486 
Figure 1: Verification of BCG inactivation at 80
o
C (purple curve), 85
o
C (blue curve) and 487 
95
o
C (green curve). The control (black curve) was live (unheated) BCG culture inoculated 488 
into same growth medium. Growth in the control was confirmed by the increase in the OD 489 
of the culture over the incubation period.    490 
 491 
Figure 2: The effect of heat killing on bacterial load estimated by 16S rRNA as a marker. 492 
2A) Bacterial load estimated from in vitro BCG cultures and 2B) bacterial load estimated 493 
from tuberculosis positive sputa. Error bars are standard error of the mean (n=18 and 20 494 
replicates for A and B respectively).  495 
 496 
Figure 3: The effect of heat killing on bacterial load estimated by non-16S rRNA RNA 497 
species as markers. 3A) Bacterial load measured by Transfer messenger RNA (tmRNA), 498 
3B) pre-16S rRNA and 3C) RNA polymerase B (rpoB). Error bars are standard error of 499 
the mean (n=replicates per RNA species per temperature). 500 
 501 
Figure 4: A plot of the RNA species specific average bacterial load loss following heat 502 
killing of cells at different temperatures. The lowest lost was in with 16S rRNA in BCG 503 
pure culture and highest was with rpoB in sputum. BCG = BCG pure culture, Mtb = Mtb 504 
in patient sputum. Errors are standard error of the mean.  505 
 506 
 507 
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